ReproGo

ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages.

The company's manufacturing approach produces stem cell-derived vascular cells and organoids through a xeno-free, low-dose process designed for regulatory compliance and scalability.

Lead applications target diabetic foot ulcers and ischaemic vascular conditions associated with diabetes and cardiovascular disease.